What to expect when you take Busulfan and have Pancytopenia?

Do you take Busulfan and have Pancytopenia? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and find Care Guides.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Sep, 15, 2018

927 reports have been studied.


Females aged 50 to 59 :

366 related reports were analyzed:

Most common symptoms:

Acute graft versus host disease
  • 15.3% for females aged 50 (±5) who take Busulfan
Acute graft versus host disease in intestine
  • 6.56% for females aged 50 (±5) who take Busulfan
Acute graft versus host disease in skin
  • 9.02% for females aged 50 (±5) who take Busulfan
Anorexia
  • 6.83% for females aged 50 (±5) who take Busulfan
Chronic graft versus host disease
  • 8.2% for females aged 50 (±5) who take Busulfan
Cytomegalovirus infection
  • 6.01% for females aged 50 (±5) who take Busulfan
Cytomegalovirus viraemia
  • 6.28% for females aged 50 (±5) who take Busulfan
Diarrhea
  • 6.83% for females aged 50 (±5) who take Busulfan
Febrile neutropenia
  • 10.38% for females aged 50 (±5) who take Busulfan
Fever
  • 9.02% for females aged 50 (±5) who take Busulfan
Graft versus host disease
  • 9.84% for females aged 50 (±5) who take Busulfan
Malaise
  • 5.74% for females aged 50 (±5) who take Busulfan
Nausea
  • 10.38% for females aged 50 (±5) who take Busulfan
Pneumonia
  • 7.65% for females aged 50 (±5) who take Busulfan
Sepsis
  • 6.83% for females aged 50 (±5) who take Busulfan
Stomatitis
  • 8.2% for females aged 50 (±5) who take Busulfan
Thrombocytopenia
  • 7.1% for females aged 50 (±5) who take Busulfan

Most common co-existing conditions:

Acute myeloid leukaemia
  • 12.57% for females aged 50 (±5) who take Busulfan
Bone marrow conditioning regimen
  • 20.49% for females aged 50 (±5) who take Busulfan
Graft versus host disease
  • 5.74% for females aged 50 (±5) who take Busulfan
Stem cell transplant
  • 37.43% for females aged 50 (±5) who take Busulfan
back to top

Males aged 50 to 59 :

561 related reports were analyzed:

Most common symptoms:

Acute graft versus host disease
  • 11.41% for males aged 50 (±5) who take Busulfan
Acute kidney failure
  • 5.17% for males aged 50 (±5) who take Busulfan
Anorexia
  • 5.53% for males aged 50 (±5) who take Busulfan
Cytomegalovirus infection
  • 8.2% for males aged 50 (±5) who take Busulfan
Diarrhea
  • 8.38% for males aged 50 (±5) who take Busulfan
Febrile neutropenia
  • 8.02% for males aged 50 (±5) who take Busulfan
Fever
  • 11.41% for males aged 50 (±5) who take Busulfan
Graft versus host disease
  • 12.48% for males aged 50 (±5) who take Busulfan
Malaise
  • 5.53% for males aged 50 (±5) who take Busulfan
Nausea
  • 8.02% for males aged 50 (±5) who take Busulfan
Pneumonia
  • 6.6% for males aged 50 (±5) who take Busulfan
Rashes
  • 6.6% for males aged 50 (±5) who take Busulfan
Sepsis
  • 6.42% for males aged 50 (±5) who take Busulfan
Stomatitis
  • 7.84% for males aged 50 (±5) who take Busulfan
Thrombocytopenia
  • 7.13% for males aged 50 (±5) who take Busulfan

Most common co-existing conditions:

Acute myeloid leukaemia
  • 6.06% for males aged 50 (±5) who take Busulfan
Bone marrow conditioning regimen
  • 20.86% for males aged 50 (±5) who take Busulfan
Graft versus host disease
  • 7.13% for males aged 50 (±5) who take Busulfan
Stem cell transplant
  • 33.51% for males aged 50 (±5) who take Busulfan
back to top

Related studies

busulfan

Busulfan has active ingredients of busulfan. (latest outcomes from Busulfan 5,832 users)

pancytopenia

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets) has been reported by people with multiple myeloma, rheumatoid arthritis, high blood pressure, preventive health care, hepatitis c (latest reports from 43,680 Pancytopenia patients).

Busulfan and Pancytopenia

Related publications that referenced our studies


Analysis tools (to study 506 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Busulfan, Pancytopenia

Recent updates

General studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.